SCHEMBL405763

SCHEMBL405763

c1ccc(C2=NN=N[N]2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
MAPK1 P28482 2/20 0.38
NOTUM Q6P988 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
ATM Q13315 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
POLB P06746 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
ADORA1 P30542 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578453 0.77 MAPT (0.48) ALDH1A1RAB9ANPC1MAPK1NOTUM
SCHEMBL7852981 0.73 NOTUM (0.42) ALDH1A1RAB9ANPC1NOTUMSMN1; SMN2
SCHEMBL7682660 0.69 ALDH1A1 (0.47) ALDH1A1RAB9ANPC1MAPK1NOTUM
SCHEMBL1855865 0.68 ALDH1A1 (0.40) ALDH1A1RAB9ANPC1MAPK1NOTUM
SCHEMBL21151453 0.67 ALDH1A1 (0.53) ALDH1A1RAB9ANPC1MAPK1NOTUM
SCHEMBL20488923 0.67 ALDH1A1 (0.43) ALDH1A1RAB9ANPC1MAPK1KMT2A
Biphenyl SCHEMBL1358618 0.61 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1MAPK1NOTUM
Biphenyl SCHEMBL4002609 0.61 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1MAPK1NOTUM
Biphenyl SCHEMBL2548048 0.61 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1MAPK1NOTUM
Biphenyl SCHEMBL164 0.61 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1MAPK1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024083020-A1 COMPOSITION FOR SELECTIVELY ETCHING ALUMINUM OXIDE 安集微电子科技(上海)股份有限公司 2024-04-25 WO claimed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
EP-1799677-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS Ranbaxy Laboratories Limited (IN) 2007-06-27 EP claimed
WO-2006038100-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2006-04-13 WO claimed
US-20050261449-A1 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENT INC. 2005-11-24 US claimed
JP-59001472-A None JP disclosed
WO-2024083020-A1 COMPOSITION FOR SELECTIVELY ETCHING ALUMINUM OXIDE 安集微电子科技(上海)股份有限公司 2024-04-25 WO disclosed
US-8361627-B2 Anti-corrosion layer for aluminum and magnesium alloys EADS DEUTSCHLAND GMBH (DE) 2013-01-29 US disclosed
US-20120021232-A1 ANTI-CORROSION LAYER FOR ALUMINUM AND MAGNESIUM ALLOYS TECHNISCHE UNIVERSITÄT WIEN (AT) 2012-01-26 US disclosed
EP-2379623-A1 ANTI-CORROSION LAYER FOR ALUMINUM AND MAGNESIUM ALLOYS EADS Deutschland GmbH (DE) 2011-10-26 EP disclosed
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2010-11-11 US disclosed
WO-2010081757-A1 ANTI-CORROSION LAYER FOR ALUMINUM AND MAGNESIUM ALLOYS EADS DEUTSCHLAND GMBH (DE) 2010-07-22 WO disclosed
US-4840887-A USEFUL GROUP RELEASED BY CLEAVAGE BETWEEN SULFONYL GROUP AND A NITROGEN, SULFUR OR OXYGEN ATOM; STABILITY FUJI PHOTO FILM CO., LTD. (JP) 1989-06-20 US disclosed
EP-0306833-A2 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1989-03-15 EP disclosed
US-4794109-A 6-hydroxy-lower alkylpenem compounds, pharmaceutical preparations that contain these compounds, and the use of the latter CIBA-GEIGY CORPORATION (US) 1988-12-27 US disclosed
EP-0110826-B1 6-HYDROXY LOWER ALKYL PENEM COMPOUNDS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE CIBA-GEIGY AG (CH) 1987-08-19 EP disclosed
EP-0148128-A2 Optically active penem compounds CIBA-GEIGY AG (CH) 1985-07-10 EP disclosed
EP-0125207-A1 2-Tetrazolylpropyl-2-penem derivatives, process for their preparation, pharmaceutical compositions containing them and their use CIBA-GEIGY AG (CH) 1984-11-14 EP disclosed
EP-0110826-A1 6-Hydroxy lower alkyl penem compounds, process for their preparation, pharmaceutical compositions containing them and their use CIBA-GEIGY AG (CH) 1984-06-13 EP disclosed
JP-S591472-A TRIIODOALLYL COMPOUND, PREPARATION AND ANTIMICROBIAL AND ANTIFUNGAL AGENT CONTAINING THE SAME AS ACTIVE CONSTITUENT MEIJI SEIKA KAISHA LTD 1984-01-06 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS OXA1L, PDK4, MLYCD ALDH1A1 944/4885RAB9A 4328/4885NPC1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.